SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital AdmissionPeter S. Hamblin, Leon A. Bach, Rosemary Wong et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 122
Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial HomeostasisMelinda T. Coughlan, Josephine M. Forbes, Brooke E. Harcourt et al.|Diabetes|2016Cited by 57
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)DAVID N. O'NEAL, Elif I. Ekinci, Sujievvan Chandran et al.|Diabetes|2025Cited by 0
876-P: Pulsed Electric Field–Induced Duodenal Recellularization Impact on Insulin Sensitivity and Beta-Cell Function—Results from REGENT-1, an Open-Label, Prospective Study in Type 2 DiabetesElif I. Ekinci, DAVID N. O'NEAL, Adrian Sartoretto et al.|Diabetes|2025Cited by 0
892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 TrialDAVID N. O'NEAL, Elif I. Ekinci, John Apostolopoulos et al.|Diabetes|2025Cited by 0